Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 43547-001

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 43547-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of esomeprazole magnesium, showing the molecular arrangement including methoxy, methyl, nitrogen, sulfur, and magnesium ions with water molecules as hydrate components.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting the percentage maintained over a 6-month period for Esomeprazole magnesium at doses of 10 mg, 20 mg, 40 mg, and placebo. The x-axis represents months with scheduled visits, and the y-axis shows the percent maintained. The 40 mg dose maintains the highest percentage near 100%, followed by 20 mg, 10 mg, and placebo.*

FDA Label Image

Figure 3 (Image 03)

A line graph showing the percentage maintained over 6 months for patients treated with Esomeprazole magnesium capsules at 10 mg, 20 mg, and 40 mg doses compared to placebo. The y-axis represents Percentage Maintained (0 to 100), and the x-axis represents time in months with scheduled visits indicated. The 20 mg and 40 mg doses maintain higher percentages close to 100%, whereas the 10 mg dose and placebo show decreasing percentages over time.*

FDA Label Image

Figure 4 (Image 04)

Line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The vertical axis indicates the percent symptom-free, and the horizontal axis shows diary days from 0 to 28. The graph compares effectiveness over time for each dosage and placebo.*

FDA Label Image

Figure 5 (Image 05)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole magnesium 20 mg and 40 mg doses compared to placebo. The graph has three distinct trend lines representing each group, plotted with percent symptom-free on the Y-axis and diary days on the X-axis.*

FDA Label Image

20 mg (Image 06)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP, 20 mg strength. The label indicates a quantity of 30 capsules and includes manufacturer information for Zhejiang Huahai Pharmaceutical Co., Ltd., distributed by Solco Healthcare US LLC. It also lists storage instructions, dispensing guidance, and provides a link for the medication guide.*

FDA Label Image

40 mg (Image 07)

Label for Esomeprazole Magnesium delayed-release capsules, USP, 40 mg strength. The label indicates the product contains 30 capsules, is for oral use only, and is Rx only. It is manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. and distributed by Solco Healthcare US, LLC. The label includes storage instructions and directions to dispense the medication guide with each prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.